Rapid microbiology testing kits market seen rising to $7.7 billion by 2030

The rapid microbiology testing kits market is projected to grow from $5.36 billion in 2026 to $7.7 billion by 2030, driven by infectious disease pressure, food safety needs and faster diagnostics. North America led the market in 2025 as the report highlights a shift toward point-of-care and molecular testing.

Why it matters: - Rapid microbiology testing kits help detect pathogens faster than conventional methods. - Faster results support earlier treatment, better infection control and quicker quality checks in healthcare, food safety and pharmaceuticals. - The market outlook points to stronger demand as antimicrobial resistance and disease surveillance needs rise.

What happened: - The Business Research Company published a 2026 report on the global rapid microbiology testing kits market. - The report estimates the market will rise from $5.28 billion in 2025 to $5.36 billion in 2026. - The report projects the market will reach $7.7 billion by 2030. - The report cites a 1.5% CAGR for 2025-2026 and a 9.5% CAGR through 2030.

The details: - The report links near-term growth to outbreaks of infectious diseases, limits of traditional testing, regulatory focus on safety, growth in clinical diagnostics and expansion in pharmaceutical manufacturing. - Longer-term growth is tied to antimicrobial resistance, demand for faster results, decentralized testing, technology upgrades and wider disease surveillance programs. - The report says key trends include faster infection diagnosis, greater use of point-of-care testing, more adoption in pharmaceutical quality control, stronger food safety testing and a shift from culture-based to molecular methods. - The report says rapid microbiology testing offers higher sensitivity and faster results than conventional microbiological methods. - The report says these kits are used to diagnose infectious diseases promptly and support quality control in multiple industries. - The report says North America led the global market in 2025. - Western Europe ranked second in market size in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and future trend analysis. - A free sample of the report is available. - The full report is available.

Between the lines: - The projected jump from low single-digit growth to 9.5% CAGR suggests the market is moving from steady adoption to broader operational reliance. - Rising tuberculosis cases in the U.S., cited by the report from CDC data, illustrate why demand for faster diagnostics is increasing. - Food recalls in the U.S. rose from 454 in 2020 to 547 in 2023, according to Food Safety magazine, reinforcing the case for rapid pathogen detection in supply chains.

What's next: - The market will likely track demand for quicker diagnostic turnaround, stronger surveillance and more molecular testing platforms. - Pharmaceutical quality control and food safety testing may remain important growth areas as regulations and risk management tighten. - Regional leadership may stay concentrated in North America and Western Europe unless adoption accelerates faster in Asia-Pacific and other emerging markets.